Literature DB >> 9648504

Omega 3 fatty acid status in patients with retinitis pigmentosa.

D R Hoffman1, D G Birch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9648504     DOI： 10.1159/000059653

Source DB:  PubMed          Journal:  World Rev Nutr Diet        ISSN： 0084-2230            Impact factor:   0.575


× No keyword cloud information.
  4 in total

1.  Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.

Authors:  Dennis R Hoffman; Dianna K Hughbanks-Wheaton; N Shirlene Pearson; Gary E Fish; Rand Spencer; Alison Takacs; Martin Klein; Kirsten G Locke; David G Birch
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

Review 2.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

3.  High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice.

Authors:  Feng Li; Lea D Marchette; Richard S Brush; Michael H Elliott; Kimberly R Davis; Ashley G Anderson; Robert E Anderson
Journal:  Mol Vis       Date:  2010-08-18       Impact factor: 2.367

4.  Intravitreal docosahexaenoic acid in a rabbit model: preclinical safety assessment.

Authors:  Rosa Dolz-Marco; Roberto Gallego-Pinazo; M Dolores Pinazo-Duran; Sheila Pons-Vázquez; Joan Carles Domingo-Pedro; Manuel Díaz-Llopis
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.